Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB-BCMM vs ELUXADOLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB-BCMM vs ELUXADOLINE: Safety Overview

Metric ELRANATAMAB-BCMM ELUXADOLINE
Total FAERS Reports 570 2,353
Deaths Reported 120 37
Death Rate 21.1% 1.6%
Hospitalizations 168 413
Average Patient Age 69.5 yrs 57.4 yrs
% Female Patients 49.4% 77.7%
FDA Approval Date N/A Mar 14, 2025
Manufacturer N/A Allergan, Inc.
Route N/A ORAL
Marketing Status N/A Prescription